$145 Million is the total value of Nan Fung Group Holdings Ltd's 42 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | Sell | KARUNA THERAPEUTICS INC | $44,347,692 | -18.4% | 225,688 | -6.6% | 30.56% | -11.9% |
| ILMN | ILLUMINA INC | $24,101,431 | +6.0% | 119,196 | 0.0% | 16.61% | +14.4% | |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $20,313,442 | -10.2% | 368,665 | -27.9% | 14.00% | -3.1% |
| SGEN | SEAGEN INC | $6,052,307 | -6.1% | 47,096 | 0.0% | 4.17% | +1.4% | |
| REPL | Buy | REPLIMUNE GROUP INC | $5,150,021 | +92.2% | 189,339 | +22.0% | 3.55% | +107.4% |
| EXSCIENTIA PLCads | $4,546,757 | -35.1% | 853,050 | 0.0% | 3.13% | -29.9% | ||
| XENE | XENON PHARMACEUTICALS INC | $4,510,003 | +9.2% | 114,380 | 0.0% | 3.11% | +17.9% | |
| SOMALOGIC INC | $4,258,361 | -13.4% | 1,696,558 | 0.0% | 2.93% | -6.6% | ||
| KDNY | CHINOOK THERAPEUTICS INC | $2,985,490 | +33.3% | 113,950 | 0.0% | 2.06% | +43.8% | |
| RANI THERAPEUTICS HLDGS INC | $2,912,146 | -38.4% | 493,584 | 0.0% | 2.01% | -33.5% | ||
| INCY | INCYTE CORP | $2,762,285 | +20.5% | 34,391 | 0.0% | 1.90% | +30.1% | |
| BGNE | BEIGENE LTDsponsored adr | $2,644,119 | +63.1% | 12,022 | 0.0% | 1.82% | +76.0% | |
| ISEE | IVERIC BIO INC | $2,397,577 | +19.3% | 111,984 | 0.0% | 1.65% | +28.9% | |
| EAR | Buy | EARGO INC | $1,700,907 | -43.9% | 2,958,099 | +2.5% | 1.17% | -39.4% |
| BOLT | BOLT BIOTHERAPEUTICS INC | $1,517,038 | -12.2% | 1,166,952 | 0.0% | 1.04% | -5.2% | |
| AVTE | New | AEROVATE THERAPEUTICS INC | $1,483,049 | – | 50,616 | +100.0% | 1.02% | – |
| MRUS | New | MERUS N V | $1,450,313 | – | 93,750 | +100.0% | 1.00% | – |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $1,117,838 | +32.9% | 136,655 | -5.7% | 0.77% | +43.4% |
| EXEL | EXELIXIS INC | $1,029,768 | +2.3% | 64,200 | 0.0% | 0.71% | +10.4% | |
| Sell | ENTRADA THERAPEUTICS INC | $994,829 | -55.4% | 73,582 | -48.0% | 0.68% | -51.9% | |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $946,982 | – | 32,520 | +100.0% | 0.65% | – |
| GRTX | GALERA THERAPEUTICS INC | $913,702 | -14.4% | 613,223 | 0.0% | 0.63% | -7.5% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $632,841 | +22.2% | 6,115 | 0.0% | 0.44% | +31.7% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $567,554 | -13.6% | 370,950 | 0.0% | 0.39% | -6.7% | |
| FGEN | Buy | FIBROGEN INC | $546,378 | +184.6% | 34,106 | +131.1% | 0.38% | +205.7% |
| TVTX | New | TRAVERE THERAPEUTICS INC | $538,494 | – | 25,606 | +100.0% | 0.37% | – |
| KALV | KALVISTA PHARMACEUTICALS INC | $532,147 | -53.4% | 78,720 | 0.0% | 0.37% | -49.7% | |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $509,038 | +18.4% | 4,168 | 0.0% | 0.35% | +28.1% | |
| BMEA | New | BIOMEA FUSION INC | $505,800 | – | 60,000 | +100.0% | 0.35% | – |
| ACAD | ACADIA PHARMACEUTICALS INC | $477,345 | -2.8% | 29,984 | 0.0% | 0.33% | +5.1% | |
| ALXO | ALX ONCOLOGY HLDGS INC | $472,777 | +17.9% | 41,950 | 0.0% | 0.33% | +27.3% | |
| AFMD | Buy | AFFIMED N V | $461,865 | +176.6% | 372,472 | +358.9% | 0.32% | +197.2% |
| ARGX | ARGENX SEsponsored adr | $420,501 | +7.3% | 1,110 | 0.0% | 0.29% | +16.0% | |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $343,076 | – | 1,182 | +100.0% | 0.24% | – |
| New | GITLAB INC | $313,990 | – | 6,910 | +100.0% | 0.22% | – | |
| STSA | SATSUMA PHARMACEUTICALS INC | $160,110 | -85.0% | 177,900 | 0.0% | 0.11% | -83.8% | |
| KOD | KODIAK SCIENCES INC | $140,494 | -7.6% | 19,622 | 0.0% | 0.10% | 0.0% | |
| NRIX | New | NURIX THERAPEUTICS INC | $126,270 | – | 11,500 | +100.0% | 0.09% | – |
| ABCL | ABCELLERA BIOLOGICS INC | $126,838 | +2.3% | 12,521 | 0.0% | 0.09% | +10.1% | |
| SYBX | SYNLOGIC INC | $52,162 | -19.8% | 68,634 | 0.0% | 0.04% | -12.2% | |
| CERS | CERUS CORP | $51,728 | +1.4% | 14,172 | 0.0% | 0.04% | +9.1% | |
| NVTA | INVITAE CORP | $21,087 | -24.7% | 11,337 | 0.0% | 0.02% | -16.7% | |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -8,265 | -100.0% | -0.13% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -5,642 | -100.0% | -0.13% | – |
| OTIC | Exit | OTONOMY INC | $0 | – | -851,000 | -100.0% | -0.16% | – |
| Exit | 2SEVENTY BIO INC | $0 | – | -40,273 | -100.0% | -0.37% | – | |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -35,830 | -100.0% | -1.18% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 10 | Q3 2023 | 34.7% |
| HARMONY BIOSCIENCES HLDGS IN | 10 | Q3 2023 | 21.3% |
| XENON PHARMACEUTICALS INC | 10 | Q3 2023 | 3.1% |
| BOLT BIOTHERAPEUTICS INC | 10 | Q3 2023 | 5.6% |
| GALERA THERAPEUTICS INC | 10 | Q3 2023 | 1.9% |
| KALVISTA PHARMACEUTICALS INC | 10 | Q3 2023 | 1.8% |
| EXELIXIS INC | 10 | Q3 2023 | 1.1% |
| DBV TECHNOLOGIES S A | 10 | Q3 2023 | 0.6% |
| ALX ONCOLOGY HLDGS INC | 10 | Q3 2023 | 1.0% |
| ILLUMINA INC | 9 | Q3 2023 | 21.5% |
View Nan Fung Group Holdings Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eargo, Inc. | December 16, 2022 | 2,958,099 | 0.7% |
| Stealth BioTherapeutics Corp | January 09, 2020 | 20,240,817 | 4.8% |
| New Frontier Health Corp | January 02, 2020 | 9,650,000 | 7.3% |
View Nan Fung Group Holdings Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-16 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Nan Fung Group Holdings Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.